BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Significant Decline in Short Interest

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the recipient of a large drop in short interest in January. As of January 31st, there was short interest totalling 313,800 shares, a drop of 61.7% from the January 15th total of 820,000 shares. Currently, 2.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 3,880,000 shares, the short-interest ratio is currently 0.1 days.

BioNexus Gene Lab Trading Down 2.4 %

Shares of NASDAQ:BGLC traded down $0.01 during midday trading on Friday, reaching $0.37. 31,918 shares of the company’s stock traded hands, compared to its average volume of 411,840. BioNexus Gene Lab has a 1 year low of $0.21 and a 1 year high of $1.33. The company has a fifty day simple moving average of $0.34 and a two-hundred day simple moving average of $0.37.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.